1) Hemophagocytic lymphohistiocytosis
噬血淋巴组织细胞增生症
1.
Clinical Study on Severe Infectious Mononucleosis and Hemophagocytic Lymphohistiocytosis;
重症传染性单核细胞增多症及噬血淋巴组织细胞增生症临床研究
2) hemophagocytic lymphohistiocytosis
噬血细胞性淋巴组织细胞增生症
1.
Objective To discuss the clinical characteristic and prognosis of the hemophagocytic lymphohistiocytosis(HLH).
目的探讨噬血细胞性淋巴组织细胞增生症(HLH)的临床特点及预后,初步评价早期化疗疗效。
2.
Objective: To Investigate the clinical features,risk factors and rational administrations of hemophagocytic lymphohistiocytosis(HLH).
目的:探讨噬血细胞性淋巴组织细胞增生症的临床表现特征,影响HLH预后的危险因素及合理用药。
3.
Objective To explore the clinical characteristics and influential factors on prognosis of hemophagocytic lymphohistiocytosis(HLH)in children.
目的探讨儿童噬血细胞性淋巴组织细胞增生症(HLH)的临床特点及预后影响因素。
3) hemophagocytic lymphohistiocytosis
噬血细胞淋巴组织细胞增生症
1.
Diagnosis,immunochemotherapy and analysis of associated causes for hemophagocytic lymphohistiocytosis:reports of 23 pediatric cases
儿童噬血细胞淋巴组织细胞增生症23例临床分析
4) hemophagocytic lymphohistiocytosis
噬血细胞性淋巴组织细胞增多症
1.
This study was aimed to explore the level of glycosylated ferritin in the patients with secondary hemophagocytic lymphohistiocytosis(HLH) and its diagnostic significance.
本研究探讨血清糖化铁蛋白在诊断继发性噬血细胞性淋巴组织细胞增多症(HLH)中的意义。
2.
The aim of study was to establish an accurate and stable technique for the detection of NK cell activity in the diagnosis of hemophagocytic lymphohistiocytosis(HLH).
本研究目的旨在建立一种准确、稳定的NK细胞杀伤活性检测方法,应用于获得性噬血细胞性淋巴组织细胞增多症诊断。
3.
The aim of this study was to investigate the clinical features of acquired hemophagocytic lymphohistiocytosis(HLH) complicated with hepatic dysfunction.
本研究探讨获得性噬血细胞性淋巴组织细胞增多症(hemophagocytic lymphohistiocytosis,HLH)肝功能损害的临床特点。
6) hemophagocytic lymphohistiocytosis
嗜血淋巴组织细胞增生症
1.
Objective To analyze virological features of Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in children cases.
目的了解儿童EB病毒(Epstein-Barr virus,EBV)相关性嗜血淋巴组织细胞增生症(EBV-associated hemophagocyticlymphohistiocytosis,EBV-HLH)的血清学EB病毒抗体和病毒复制水平等病毒学特征。
2.
Objective: To provide clinical data for controlling Epstein-Barr virus associated hemophagocytic lymphohistiocytosis(EBV-HLH) by investigat- -ing the clinical features, diagnosis, treatment and outcome of EBV associated severe infectious mononucleosis(severe IM) and EBV-HLH, and analyzing the risk factors for the presence of EBV-HLH.
目的:探讨EB病毒相关性重症传染性单核细胞增多症(severe infectious mononucleosis,简称重症IM)和EB病毒相关性嗜血淋巴组织细胞增生症(Epstein-Barr virus associated hemophagocytic lympho- -histiocytosis,EBV-HLH)的临床特点、诊断标准、治疗及疗效,并分析预测EBV-HLH发生的危险因素,为防治EBV-HLH提供临床依据。
补充资料：淋巴结病和窦性组织细胞增生症
淋巴结病和窦性组织细胞增生症
〖HT5”SS〗lymplh ?adenopathy and sinus histiocytosis
属Ⅱ类组织细胞增生症。其特点是发热、白细胞增多、颈淋巴结肿大。病理改变为淋巴结包膜下及髓窦组织细胞增生，光镜下很似朗格汉斯细胞组织细胞增生症，但电镜下不见Birbeck颗粒，CDIa阴性。病变不侵犯骨骼、肝、脾、肺、皮肤等组织，仅限于淋巴结。可有暂时性免疫功能低下。非恶性肿瘤。预后较好。对有严重淋巴结破坏者，化疗效果较好。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条